AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-4380699_ITM" title="Facts and information about Gemzar/Taxol combo approved.(Products)">Gemzar/Taxol combo approved.(Products)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Gemzar/Taxol combo approved.(Products)
Gemzar (gemcitabine HCl), in combination with Taxol (paclitaxel) is approved for the first-line treatment of metastatic breast cancer after failure of prior ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- GPC Biotech's satraplatin enters Ph II as Taxol combo.(Combination drug therapy...
- Newspaper article from: Pharma Marketletter December 19, 2005 700+ words
German drugmaker GPC Biotech AG says that a Phase II study evaluating its lead drug candidate, satraplatin, in combination with Taxol (paclitaxel) as a first-line therapy in patients with unresectable advanced non-small cell lung cancer has started enrolling patients. The trial in advanced NSCLC is
- GEMZAR/Carboplatin Combination Shows Extended Median Survival Over Three-Drug...
- Press release article from: Business Wire May 20, 2002 700+ words
...2002 New research findings report that Gemzar(R) (gemcitabine HCl) in combination...men and women worldwide each year. The Gemzar and carboplatin regimen was also better...230 studies presented at ASCO in which Gemzar has been included in the combination regimen...
- Gemzar/Taxol vs Taxol alone improves survival in breast cancer study patients.
- Newspaper article from: Biotech Week July 7, 2004 700+ words
...improvement in survival when treated with a Gemzar/Taxol combination compared to patients...population. "The analysis strongly favors the Gemzar plus Taxol combination and represents...ASCO). Albain's study concludes: The Gemzar/Taxol combination is a new therapy that...
- Data Presented at ASCO Showed Gemzar and Carboplatin Improved Response Rates...
- Press release article from: Business Wire May 20, 2002 700+ words
...Today new efficacy data was presented on Gemzar(R) (gemcitabine HCI), in combination...time to progressive disease compared with Gemzar alone in patients with advanced non...Clinical Oncology (ASCO): single-agent Gemzar versus a Gemzar and carboplatin combination...
- U.S. FDA Approves Lilly's Gemzar for First-Line Treatment of Non-Small Cell...
- Press release article from: PR Newswire August 26, 1998 700+ words
Gemzar combination extends survival for patients...approved the company's anticancer agent Gemzar(R) (gemcitabine HCl) for use in combination...investigator for the pivotal trial with Gemzar (pronounced jem-zar). "Our study showed...
- Eli Lilly and Company: Gemzar Combination Delays Disease Progression In...
- Press release article from: Business Wire June 1, 2003 700+ words
...disease when they received a combination of Gemzar(R) (gemcitabine HC1) and Taxol...Oncology (ASCO) in Chicago, Illinois. The Gemzar/Taxol combination is one of the few...repeated 21-day cycles of Taxol and Gemzar (175 mg/m2 of Taxol for three hours...
- Gemzar(R) Combination Therapy Receives European Regulatory Approvals for...
- Press release article from: PR Newswire July 29, 2004 700+ words
Eli Lilly and Company's Gemzar(R) (gemcitabine), approved to...Portugal, and Romania, have approved Gemzar in combination with carboplatin, a...initial treatment.(2) "This new Gemzar combination provides women prolonged...
- Eli Lilly & Company's Gemzar recommended by Advisory Committee to FDA for...
- Press release article from: Business Wire July 24, 1995 700+ words
...HealthWire)--July 24, 1995--Gemzar(R) (gemcitabine hydrochloride...Food and Drug Administration (FDA). Gemzar is a novel nucleoside analog, which is...evaluating clinical data on the use of Gemzar in patients with advanced or metastatic...